Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Haas

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
American Journal of Clinical Oncology|April 1, 1985
Dibromodulcitol (DBD), DTIC, and actinomycin-D in disseminated malignant melanoma. A phase I-II clinical trialM K Samson, C D Haas, L H Baker, et al.
Cancer Treatment Reports|January 1, 1980
Cholestatic jaundice associated with chlorozotocinR J Belt, D McGregor, C D Haas, et al.
Investigational New Drugs|January 1, 1983
Vindesine in head and neck cancer. A Southwest Oncology Group Phase II pilot studyC D Haas, C J Fabian, R L Stephens, et al.
Investigational New Drugs|January 1, 1984
Nafazatrom: clonogenic in-vitro assessment of activity against human malignanciesC D Haas, G W Kyle, J D Crissman, et al.
American Journal of Clinical Oncology|August 1, 1984
Phase II clinical evaluation of AZQ in adenocarcinoma of the lungD A Decker, M K Samson, C D Haas, et al.
Cancer|July 1, 1978
Phase I evaluation of anguidine (diacetoxyscirpenol, NSC-141537)W Goodwin, C D Haas, C Fabian, et al.
Investigational New Drugs|January 1, 1984
Phase I evaluation of AT-125 single dose every three weeksS Taylor, R J Belt, U Joseph, et al.
Cancer|December 1, 1980
Phase I evaluation of chlorozotocin: single dose every six weeksS Taylor, R J Belt, C D Haas, et al.
Cancer Treatment Reports|December 1, 1987
Phase I study of echinomycinR Pazdur, C D Haas, L H Baker, et al.
American Journal of Clinical Oncology|August 1, 1985
Phase II evaluation of aclacinomycin-A in patients with adenocarcinoma and large cell carcinoma of the lungE Tapazoglou, C D Haas, M K Samson, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
American Journal of Clinical Oncology|April 1, 1985
Dibromodulcitol (DBD), DTIC, and actinomycin-D in disseminated malignant melanoma. A phase I-II clinical trialM K Samson, C D Haas, L H Baker, et al.
Cancer Treatment Reports|January 1, 1980
Cholestatic jaundice associated with chlorozotocinR J Belt, D McGregor, C D Haas, et al.
Investigational New Drugs|January 1, 1983
Vindesine in head and neck cancer. A Southwest Oncology Group Phase II pilot studyC D Haas, C J Fabian, R L Stephens, et al.
Investigational New Drugs|January 1, 1984
Nafazatrom: clonogenic in-vitro assessment of activity against human malignanciesC D Haas, G W Kyle, J D Crissman, et al.
American Journal of Clinical Oncology|August 1, 1984
Phase II clinical evaluation of AZQ in adenocarcinoma of the lungD A Decker, M K Samson, C D Haas, et al.
Cancer|July 1, 1978
Phase I evaluation of anguidine (diacetoxyscirpenol, NSC-141537)W Goodwin, C D Haas, C Fabian, et al.
Investigational New Drugs|January 1, 1984
Phase I evaluation of AT-125 single dose every three weeksS Taylor, R J Belt, U Joseph, et al.
Cancer|December 1, 1980
Phase I evaluation of chlorozotocin: single dose every six weeksS Taylor, R J Belt, C D Haas, et al.
Cancer Treatment Reports|December 1, 1987
Phase I study of echinomycinR Pazdur, C D Haas, L H Baker, et al.
American Journal of Clinical Oncology|August 1, 1985
Phase II evaluation of aclacinomycin-A in patients with adenocarcinoma and large cell carcinoma of the lungE Tapazoglou, C D Haas, M K Samson, et al.
Pageof 4